Naseem Zojwalla - 31 Jan 2022 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
3
Filing time
03 Feb 2022, 17:58:45 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

No securities are beneficially owned.